| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
30.04.2025 08:00:03
|
EQS-News: 11880 Solutions AG confirms efficiency strategy for fiscal year 2024: Stable revenue, significant EBITDA growth
|
EQS-News: 11880 Solutions AG
/ Key word(s): Annual Results/Annual Report
Essen, 30 April 2025 – 11880 Solutions AG successfully continued its efficiency-focused strategy in fiscal year 2024. The provider of online marketing and telephone services generated revenues of EUR 55.6 million (2023: EUR 57.1 million). EBITDA rose significantly to EUR 3.9 million (2023: EUR 2.6 million), and cash flow was positive. This demonstrates the company’s resilience amid challenging macroeconomic conditions. The digital business contributed EUR 44.3 million (2023: EUR 44.8 million) to total revenue and generated an EBITDA of EUR 3.8 million (2023: EUR 2.6 million). In the Directory Assistance segment, which ten years ago accounted for 40 percent of total revenue and generated EUR 21 million, revenue in the 2024 reporting year stood at EUR 11.4 million (2023: EUR 12.3 million). Of this, only EUR 2.7 million came from traditional directory assistance services. Since 2016, 11880 Solutions AG has successfully established a sustainable and future-proof business model with its call centre services, which now compensate for the market-driven decline in directory assistance and account for almost 80 percent of segment revenue. EBITDA in this segment amounted to EUR 0.1 million (2023: EUR 0.0 million). “We not only achieved our financial goals in fiscal year 2024 but also laid important groundwork for future growth. We are especially pleased with the successful launch of the first werkenntdenBESTEN packages for business customers, which show great potential for the future,” says Christian Maar, CEO of 11880 Solutions AG. In the current fiscal year, 11880 Solutions AG is focusing on further development and marketing of werkenntdenBESTEN: consumers can look forward to new features and attractive partner offers, while business customers will benefit from additional tools for reputation management and business analytics. For fiscal year 2025, 11880 Solutions AG expects consolidated revenue of between EUR 53 million and EUR 57 million and EBITDA of between EUR 3 million and EUR 4 million. The 2024 Annual Report of 11880 Solutions AG is available for download at:
Contact: Anja Meyer 11880 Solutions AG Tel.: 0201 / 8099-188 E-Mail: anja.meyer@11880.com
30.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | 11880 Solutions AG |
| Hohenzollernstraße 24 | |
| 45128 Essen | |
| Germany | |
| Phone: | 0201-80990 |
| E-mail: | info@11880.com |
| Internet: | www.11880.com |
| ISIN: | DE0005118806, DE0005118806, , |
| WKN: | 511880, 511880 |
| Indices: | Prime All Share |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2127102 |
| End of News | EQS News Service |
|
|
2127102 30.04.2025 CET/CEST
Nachrichten zu 11880 Solutions AG
Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer
Tim Schäfer live aus New York – dieses Mal mit einem spannenden Blick auf abgestürzte Blue-Chip-Aktien, bei denen sich ein Einstieg lohnen könnte. Gemeinsam mit David Kunz analysiert Tim prominente Verlierer der letzten Monate, die möglicherweise vor einer Erholung stehen.
Themen im Video:
🔹 Merck & Co. (USA) – Probleme mit Impfstoffen und Patentlaufzeiten
🔹 Pfizer – Wachstumsdruck durch auslaufende Patente
🔹 United Health – Ermittlungen und steigende Gesundheitskosten
🔹 Novo Nordisk – Abnehmspritze, Wettbewerb und Marktkorrektur
🔹 Nike – Konsumflaute und neue Konkurrenz
🔹 Estée Lauder – Kursabsturz, China-Schwäche und Hoffnung auf Turnaround
🔹 Campbell Soup – Value-Aktie mit attraktiver Dividende
🔹 Regeneron – Erfolgreiche Gründerstory mit Herausforderungen
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| 11880 Solutions AG | 0.65 | -5.84% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI und DAX gehen tiefrot ins Wochenende -- Wall Street beendet Handel leichter -- Asiens Börsen letztlich im MinusDer heimische sowie der deutsche Aktienmarkt präsentierten sich zum Wochenschluss deutlich leichter. Die Wall Street bewegte sich am letzten Handelstag der Woche abwärts. An den asiatischen Börsen waren am Freitag ebenso Abschläge zu sehen.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |